Haifa, Israel

Gera Neufeld

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 2.3

ph-index = 5

Forward Citations = 80(Granted Patents)


Company Filing History:


Years Active: 2000-2020

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Gera Neufeld

Introduction

Gera Neufeld, a prolific inventor based in Haifa, Israel, has made significant contributions to the field of medical research through his innovative inventions. With a remarkable portfolio of 16 patents, Neufeld's work focuses primarily on utilizing Semaphorin 3C variants in treating various eye diseases and cancer.

Latest Patents

Among his latest patents, Neufeld has developed inventions relating to Semaphorin 3C variants and their applications. His patented methods of treating eye diseases, particularly age-related macular degeneration (AMD), involve administering Semaphorin 3C or a modified variant that is resistant to cleavage at specific sites. These advancements showcase his ability to enhance therapeutic options for patients suffering from vision-related ailments. Additionally, Neufeld's patents cover methods for suppressing tumor growth and inhibiting metastasis through similar compositions, demonstrating the dual potential of his research in both ophthalmology and oncology.

Career Highlights

Neufeld has had a distinguished career, contributing to reputable institutions that focus on scientific advancements. He has been affiliated with the Technion Research & Development Foundation Limited and the Rappaport Family Institute for Research in the Medical Sciences, where he has made vital strides in understanding and developing new medical therapies. His dedication to research has led to numerous published works and advancements in medical science.

Collaborations

Throughout his career, Gera Neufeld has collaborated with notable professionals such as Ofra Kessler and Boaz Kigel. These partnerships have not only enriched his projects but have also propelled his innovative ideas towards practical applications in the medical field. Collaborative efforts have played a crucial role in enhancing the potential impact of his work on eye diseases and cancer treatment.

Conclusion

Gera Neufeld stands out as a significant figure in the realm of medical innovation. His extensive patent portfolio and impactful collaborations underline his commitment to advancing research in eye diseases and oncology. As he continues to innovate, Neufeld's work promises to bring forth new treatment methodologies that will benefit countless individuals facing these serious health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…